China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 32000 participants.

Also called NCT04974138

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 32,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04974138
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04974138. Randomized; quadruple masking; primary purpose treatment. Start 2024-08-22 (actual); primary completion 2030-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
Acronym
CSPPT2-CC/CT
Condition
Hypertension
Condition
MTHFR 677 CC or CT Genotype
Condition
Elevated Plasma Homocysteine (Hcy≥10µmol/L)
Condition
Insufficient Plasma Folate Levels (<12ng/mL)
Intervention (Drug)
Amlodipine besylate
Intervention (Drug)
Amlodipine besylate and folic acid
Intervention (Drug)
Amlodipine placebos
Intervention (Drug)
Amlodipine-folic acid placebos
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd (class: industry)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Second Affiliated Hospital of Nanchang University (class: other)
Collaborator
The First People's Hospital of Lianyungang (class: other)
Collaborator
The Affiliated Hospital Of Guizhou Medical University (class: other)
Collaborator
Lianyungang Oriental Hospital (class: other)
Collaborator
Tengzhou Central People's Hospital (class: other government)
Collaborator
The First Affiliated Hospital of Bengbu Medical University (class: other)
Collaborator
Shenzhen Prospective Medical Technology Co., LTD (class: not stated)
Collaborator
Weinan Central Hospital (class: other)
Collaborator
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (class: other)
Collaborator
Loudi Central Hospital (class: other)
Collaborator
Yancheng First People's Hospital (class: other)
Collaborator
TAIHE country people's hospital (class: not stated)
Collaborator
First Affiliated Hospital of Gannan Medical University (class: other)
Collaborator
Yangjiang People's Hospital (class: other)
Collaborator
Deyang People's Hospital (class: other)
Collaborator
Bozhou people's hospital (class: not stated)
Collaborator
Lianyungang Second People's Hospital (class: not stated)
Collaborator
The Affiliated Hospital Of Southwest Medical University (class: other)
Collaborator
Chengdu Fifth People's Hospital (class: other)
Collaborator
Chizhou people's hospital (class: not stated)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 13

Record details

Record id
cardio:ct-nct04974138
Content hash
edb36c0294ddd4a0b5b6cf86c3290db5a4f21c5aae1585b3e29c07995d6419c7